December 2, 2015
Contact: Dan Weber
Edwards Co-Chairs Steering and Policy Committee Hearing on Prescription Drug Affordability
Washington, D.C. – Congresswoman Donna F. Edwards (MD-4) joined with Democratic Leader Nancy Pelosi and fellow co-chair of the Steering and Policy Committee Rep. Rosa DeLauro (CT-3) to lead a hearing on prescription drug affordability.  The hearing was entitled “Ensuring Access and Affordability of Prescription Drugs, While Spurring Innovation.”
“The intent of lifesaving drugs is just that – to save lives, not to solely fill the pockets of executives and investors of large drug companies,” Edwards said.  “We owe it to the people we serve to put a stop to the price-gouging that is bankrupting patients and overcharging Medicare, straining hospitals, and fleecing taxpayers. In today’s hearing we heard expert witnesses and real stories that highlighted the severity of prescription drug costs and the impact these costs are having on Americans.  We must continue to challenge each and every one of these drug companies, and by putting pressure on them, and even shaming them, they might change their tactics.”
A recent New York Times article highlighted just one example, saying “Valeant attracted scrutiny from some members of Congress for acquiring two old heart drugs, Isuprel and Nitropress, in February and immediately increasing their prices by more than 500 percent and 200 percent.”
To watch the entire hearing, please click here.